Is SQNM a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

1,655 people get SQNM articles and Market Currents by email alert.

Get email alerts on SQNM »

HEADLINES:

Sequenom's Management Presents at Bank of America Merrill Lynch Health Care Conference (Transcript)
Thu, May 16 • 1 Comment
5 Stocks This Growth-Oriented Hedge Fund Is Most Committed To
Insider Monkey • Sun, May 12
Sequenom's CEO Discusses Q1 2013 Results - Earnings Call Transcript
Thu, May 9
Sequenom, Inc. Reports Financial Results For The First Quarter Of 2013

PR Newswire (May 9, 2013)
Leveraging Sequenom's Upcoming Earnings Volatility
Ravi Jain • Wed, May 8 • 7 Comments
Sequenom Announces Participation At The Bank Of America Merrill Lynch Health Care Conference

PR Newswire (May 8, 2013)
Sequenom, Inc. Announces Date of First Quarter 2013 Financial Results and Conference Call

PR Newswire (Apr 25, 2013)
Scenario Analysis Yields 15% Upside For Sequenom
Ravi Jain • Wed, Apr 17 • 9 Comments
Sequenom CMM Achieves Milestone Of 100,000 MaterniT21™ Plus Tests Processed

PR Newswire (Apr 16, 2013)
Sequenom, Inc. Announces The Availability Of Heredi-T™ Cystic Fibrosis Carrier Screening LDT Through Sequenom CMM

PR Newswire (Mar 21, 2013)
Cramer's Lightning Round - Way To Go, Winnebago (3/15/13)
SA Editor Miriam Metzinger • Sun, Mar 17
Sequenom Announces Participation At The 25th Annual Roth Conference

PR Newswire (Mar 15, 2013)
Sequenom Management Presents at Barclays Capital 2013 Global Healthcare Conference (Transcript)
Wed, Mar 13
Sequenom's CEO Discusses Q4 2012 Results - Earnings Call Transcript
Thu, Mar 7
Sequenom, Inc. Reports Financial Results For The Fourth Quarter And Full Year Of 2012

PR Newswire (Mar 7, 2013)
Sequenom Announces Participation At The Barclays Global Healthcare Conference

PR Newswire (Mar 5, 2013)
VIX - Options Volatility And Market Sonar: Tuesday Recap
Erick McKitterick • Tue, Feb 26 • 4 Comments
VIX - Options Volatility And Market Sonar: Wednesday Recap
Erick McKitterick • Wed, Feb 20 • 12 Comments
Sequenom, Inc. Announces Date Of Fourth Quarter And Full Year 2012 Financial Results And Conference Call

PR Newswire (Feb 20, 2013)
Response Genetics' Competitors: Who To Watch, Who To Worry About
Bay Area Biotech • Fri, Feb 8 • 7 Comments

To learn more about Seeking Alpha Pro, click here.

Leveraging Sequenom's Upcoming Earnings Volatility
Ravi Jain • Wed, May 8 • 7 Comments
Scenario Analysis Yields 15% Upside For Sequenom
Ravi Jain • Wed, Apr 17 • 9 Comments
Taking A Flyer On This Cash-Rich Biotech With Recent Insider Buying
Bret Jensen • Fri, Aug 10, 2012 • 7 Comments
Sequenom Announces a Launch Date for Its Non-Invasive Down Syndrome Test
Prohost Biotech • Sun, May 8, 2011 • 9 Comments
Former Sequenom Executive Charged With Faking It
Derek Lowe • Thu, Jun 3, 2010 • 20 Comments
Sequenom Story Still Unfolding
Prohost Biotech • Wed, Mar 24, 2010 • 5 Comments
Sequenom: Missing Analysts' Expectations by Five Cents Caused a Sell-Off?
Prohost Biotech • Thu, Mar 18, 2010 • 13 Comments
Bulls Chase Sequenom on Upgrade
optionMONSTER • Tue, Mar 2, 2010 • 2 Comments
Sequenom: The Future Is Looking Up
TraderMark • Tue, Mar 2, 2010 • 10 Comments
Things Can Get Even Worse for Sequenom
Derek Lowe • Thu, Jan 28, 2010 • 6 Comments
Sequenom: Heads Roll, Investors Struggle to Find the Bottom
Brendan Wagner • Wed, Sep 30, 2009 • 5 Comments
Something's Rotten in the State of Sequenom (But Who Really Cares?)
TraderMark • Tue, Sep 29, 2009 • 3 Comments
Sequenom Reaches Important Milestone
Prohost Biotech • Wed, Sep 23, 2009
Who Sold Sequenom Last Week and Why?
Prohost Biotech • Mon, Aug 10, 2009 • 5 Comments
Sequenom and the Small Cap Biotech Bipolar Experience
TraderMark • Tue, Jun 2, 2009 • 2 Comments
The Sequenom Syndrome
Mike Huckman • Thu, Apr 30, 2009
Sequenom Misses Earnings Again
TraderMark • Thu, Feb 12, 2009 • 1 Comment
Sequenom Is Put to the Test
Mike Huckman • Fri, Jan 30, 2009 • 2 Comments
Sequenom Misses, but Who Cares?
TraderMark • Thu, Oct 30, 2008
Sequenom Down on Threat of Competition
TraderMark • Tue, Oct 7, 2008 • 1 Comment

5 Stocks This Growth-Oriented Hedge Fund Is Most Committed To
Insider Monkey • Sun, May 12
Cramer's Lightning Round - Way To Go, Winnebago (3/15/13)
SA Editor Miriam Metzinger • Sun, Mar 17
VIX - Options Volatility And Market Sonar: Tuesday Recap
Erick McKitterick • Tue, Feb 26 • 4 Comments
VIX - Options Volatility And Market Sonar: Wednesday Recap
Erick McKitterick • Wed, Feb 20 • 12 Comments
Response Genetics' Competitors: Who To Watch, Who To Worry About
Bay Area Biotech • Fri, Feb 8 • 7 Comments
VIX - Options Volatility And Market Sonar: Tuesday Recap
Erick McKitterick • Tue, Jan 29 • 8 Comments
VIX - Options Volatility And Market Sonar: Friday Recap
Erick McKitterick • Fri, Jan 25 • 6 Comments
First Half Of 2013 To Be A Critical Time For Exact Sciences
Josh Hutheson • Wed, Jan 9 • 1 Comment
8 Stocks Under $5 On Winning Streaks
Kapitall • Tue, Dec 18, 2012
Trovagene's Foray Into The Conventions Of Molecular Diagnostics
J. King • Thu, Nov 15, 2012
7 Biotech Stocks Trading At Steep Discount To Target Price
Kapitall • Thu, Nov 15, 2012
5 High-Growth Biotech Stocks With Bearish Short Trends
Kapitall • Mon, Nov 5, 2012 • 7 Comments
3 Sub $10 Heavily Shorted High Volume Small Cap Biotechs Rated Buy With Momentum
R.S. Analytics • Thu, Sep 20, 2012 • 1 Comment
4 Highly Liquid Small Cap Healthcare Stocks Set For Growth
ZetaKap • Tue, Sep 4, 2012 • 3 Comments
2 Biotech Stocks I'm Considering This Thursday
Matt Schilling • Thu, Aug 16, 2012 • 5 Comments
Notable Insider Buys Filed On August 9
StockPandit • Fri, Aug 10, 2012 • 1 Comment
Notable Insider Buys Filed On August 6
StockPandit • Tue, Aug 7, 2012
5 Major Insider Buys Filed On August 2 After The Market Close
Markus Aarnio • Fri, Aug 3, 2012 • 21 Comments
3 Analyst Endorsed Small Cap Biotech Stocks Slated For Growth
ZetaKap • Thu, Aug 2, 2012
4 Healthcare Stocks Primed For Growth
ZetaKap • Fri, Jul 27, 2012

Sequenom's Management Presents at Bank of America Merrill Lynch Health Care Conference (Transcript)
Thu, May 16 • 1 Comment
Sequenom's CEO Discusses Q1 2013 Results - Earnings Call Transcript
Thu, May 9
Sequenom Management Presents at Barclays Capital 2013 Global Healthcare Conference (Transcript)
Wed, Mar 13
Sequenom's CEO Discusses Q4 2012 Results - Earnings Call Transcript
Thu, Mar 7
Sequenom Presents at JPMorgan Global Healthcare Conference (Transcript)
Wed, Jan 9 • 2 Comments
Sequenom's CEO Presents at Lazard Capital Markets 9th Annual Healthcare Conference (Transcript)
Tue, Nov 13, 2012
Sequenom's CEO Discusses Q3 2012 Results - Earnings Call Transcript
Thu, Nov 8, 2012
Sequenom's CEO Discusses Q2 2012 Results - Earnings Call Transcript
Thu, Jul 26, 2012
Sequenom's Management Presents at Bank of America Merrill Lynch 2012 Healthcare Conference (Transcript)
Tue, May 15, 2012
Sequenom's CEO Discusses Q1 2012 Results - Earnings Call Transcript
Thu, May 3, 2012 • 6 Comments
Sequenom's Management Presents at Barclays Capital 2012 Global Healthcare Conference (Transcript)
Tue, Mar 20, 2012
Sequenom's CEO Discusses Q4 2011 Results - Earnings Call Transcript
Wed, Mar 7, 2012
Sequenom CEO Presents at 30th Annual J.P. Morgan Healthcare Conference (Transcript)
Wed, Jan 25, 2012
Sequenom's CEO Presents at Lazard Capital Markets 8th Annual Healthcare Conference - Conference Call Transcript
Wed, Nov 30, 2011
Sequenom CEO Hosts 2011 Analyst and Investor Day
Tue, Nov 15, 2011
Sequenom CEO Discusses Q3 2011 Results - Earnings Call Transcript
Fri, Nov 4, 2011
Sequenom's CEO Hosts Launch of MaterniT21 - Conference Call Transcript
Tue, Nov 1, 2011
Sequenom's CEO Discusses Q2 2011 Results - Earnings Call Transcript
Sat, Aug 6, 2011
Sequenom's CEO Discusses Q1 2011 Results - Earnings Call Transcript
Thu, May 5, 2011
Sequenom CEO Discusses Q4 2010 Results - Earnings Call Transcript
Tue, Mar 8, 2011

Sequenom, Inc. Reports Financial Results For The First Quarter Of 2013

PR Newswire (May 9, 2013)
Sequenom Announces Participation At The Bank Of America Merrill Lynch Health Care Conference

PR Newswire (May 8, 2013)
Sequenom, Inc. Announces Date of First Quarter 2013 Financial Results and Conference Call

PR Newswire (Apr 25, 2013)
Sequenom CMM Achieves Milestone Of 100,000 MaterniT21™ Plus Tests Processed

PR Newswire (Apr 16, 2013)
Sequenom, Inc. Announces The Availability Of Heredi-T™ Cystic Fibrosis Carrier Screening LDT Through Sequenom CMM

PR Newswire (Mar 21, 2013)
Lightning Round: Cheniere Energy Partners, Winnebago & More

at CNBC.com (Mar 15, 2013)
Sequenom Announces Participation At The 25th Annual Roth Conference

PR Newswire (Mar 15, 2013)
Sequenom, Inc. Reports Financial Results For The Fourth Quarter And Full Year Of 2012

PR Newswire (Mar 7, 2013)
Sequenom Announces Participation At The Barclays Global Healthcare Conference

PR Newswire (Mar 5, 2013)
Sequenom, Inc. Announces Date Of Fourth Quarter And Full Year 2012 Financial Results And Conference Call

PR Newswire (Feb 20, 2013)
Sequenom CMM's MaterniT21 PLUS LDT Now Reporting On Gender-Specific Chromosomal Abnormalities

PR Newswire (Feb 4, 2013)
Movers & Shakers: Monday’s biggest gaining and declining stocks

at MarketWatch.com (Jan 7, 2013)
Sequenom Announces Preliminary 2012 Operational Highlights

PR Newswire (Jan 6, 2013)
Sequenom Announces Participation At 31st Annual JP Morgan Healthcare Conference

PR Newswire (Jan 2, 2013)
Sequenom Provides Update On Status Of Patent For Methods Of Detecting Fetal Aneuploidy

PR Newswire (Dec 14, 2012)
Sequenom Announces Leadership Appointments

PR Newswire (Dec 11, 2012)
Sequenom, Inc. Announces Issuance Of Patent For Methods Of Detecting Fetal Aneuploidy

PR Newswire (Dec 6, 2012)
Sequenom Announces Participation at Oppenheimer 23rd Annual Healthcare Conference

PR Newswire (Dec 6, 2012)
The American College of Obstetricians and Gynecologists Committee on Genetics and the Society for Maternal-Fetal Medicine Publications Committee Recommend Noninvasive Prenatal Testing for Fetal Aneuploidy

PR Newswire (Nov 21, 2012)
Study Shows Sequenom CMM's RetnaGene LDT Accurately Predicts Risk of Progression to Wet Form of AMD

PR Newswire (Nov 12, 2012)

SQNM vs. ETF Alternatives

Company Description

We are a diagnostic testing and genetics analysis company committed to providing products, services, diagnostic testing, applications and genetic analysis products that translate the results of genomic science into solutions for biomedical research, translational research, molecular medicine... More

Sector: Healthcare

Industry: Biotechnology

Country: United States

All
| Earnings
| Dividends
| M&A
| On the move

Monday, May 13, 11:53 AM Credit Suisse upgrades Sequenom (SQNM +7.5%) to Neutral and raises its price target to $4.50 from $4, citing decreased risk stemming from the company's five-year agreement with Blue Cross and Blue Shield (see CC) for the MaterniT21 PLUS test. Analyst Vamil Divan notes that "following daily moves in [the stock] can get one dizzy" — today is no exception — but CS sees SQNM running 175K tests in FY13 versus company projections of 150K and says that ultimately, robust volumes are enough to support the story at least for the foreseeable future. (See also: Q1 earnings) Comment! [Healthcare, On the Move]
Friday, May 10, 12:52 PM Midday top 10 gainers: UNIS +58%. DRAM +57%. VRML +26%. SREV +22%. MCP +20%. UBNT +18%. RH +18%. WCRX +17%. CSIQ +16%. SQNM +16%.
Midday top 10 losers: PTIE -48%. DRRX -41%. IFMI -34%. AFFY -26%. SRT -23%. LPDX -22%. OPTR -17%. REFR -16%. PANL -16%. TRMD -15%. Comment! [On the Move]
Friday, May 10, 9:10 AM Premarket gainers: PGNX +26%. UNIS +21%. UBNT +19%. SQNM +11%. MCP +11%. XIN +7%. NBG +6%. NTE +5%. MT +5%.
Losers: PTIE -48%. IFMI -36%. AFFY -18%. SNTS -7%. OPTR -7%. DDD -6%. MDRX -6%. LFVN -5%. Comment! [On the Move]
Thursday, May 9, 5:51 PM More on Sequenom (SQNM): Q1 misses on a per share basis as losses increase, but meets revenue estimates. Total sales jumped 158% over the prior year, led by continued growth in diagnostic sales. Total cost of revenues increased, primarily due to the significant increase in its test volumes and costs to support increased testing capacity. Shares +5% AH. Comment! [Healthcare, Earnings, On the Move]
Thursday, May 9, 4:14 PM Sequenom (SQNM): Q1 EPS loss of -$0.26 misses by $0.02. Revenue of $38.5M (+158% Y/Y) in line. (PR). Comment! [Breaking News, Earnings, Healthcare]
Thursday, May 9, 12:10 AM Notable earnings after Thursday’s close: AGO, AIRM, AL, ALIM, ANAC, ASYS, AUQ, BCEI, BID, BPZ, CALL, CPE, DAR, EGY, ET, FTK, FXEN, GXP, KTOS, LLNW, MBI, MCP, MDRX, MDVN, NGVC, NVDA, OPTR, PANL, PCLN, PDLI, PSA, RNDY, SF, SLXP, SQNM, TNGO, UBNT, ZGNX Comment! [Earnings]
Wednesday, May 8, 5:35 PM Notable earnings after Thursday’s close: AGO, AIRM, AL, ALIM, ANAC, ASYS, AUQ, BCEI, BID, BPZ, CALL, CPE, DAR, EGY, ET, FTK, FXEN, GXP, KTOS, LLNW, MBI, MCP, MDRX, MDVN, NGVC, NVDA, OPTR, PANL, PCLN, PDLI, PSA, RNDY, SF, SLXP, SQNM, TNGO, UBNT, ZGNX Comment! [Earnings]
Thursday, April 4, 8:39 AM Sequenom (SQNM) looks to retrace yesterday's losses after Wedbush says a WSJ article about proposed regulation of prenatal screening tests likely overstates the case as the FDA "has missed its window to regulate the non-invasive prenatal testing market." Analyst Zarak Khurshid upgrades the stock to Outperform from Neutral and reiterates a price target of $5. Shares +3.4% premarket. Comment! [Healthcare, On the Move]
Thursday, March 7, 4:16 PM Sequenom (SQNM): Q4 EPS of -$0.29 misses by $0.07. Revenue of $33.7M (+117% Y/Y) beats by $1.68M. Shares -2% AH. (PR) Comment! [Earnings, Breaking News, On the Move, Healthcare]
Thursday, March 7, 12:10 AM Notable earnings after Thursday’s close: AMBA, BPZ, FNSR, HRB, MED, P, SKUL, SQNM, WDAY, WPRT, ZQK Comment! [Earnings]
Wednesday, March 6, 5:35 PM Notable earnings after Thursday’s close: AMBA, BPZ, FNSR, HRB, MED, P, SKUL, SQNM, WDAY, WPRT, ZQK Comment! [Earnings]
Friday, March 1, 9:17 AM An upgrade to Overweight by Piper Jaffray has Sequenom (SQNM) up 7.5% premarket to $4.42, vs. Piper's raised price target of $6.50. Of some 10 analysts covering the maker of DNA detection and sequencing equipment, seven are at Buy or Outperform vs. just one rating it at Underperform. Comment! [Healthcare, On the Move]
Friday, March 1, 9:10 AM Premarket gainers: ISRG +9%. SHS +8%. CERS +8%. DECK +8%. SQNM +7%. BBY +6%. PGH +5%.
Losers: AT -34%. FWLT -17%. OVTI -15%. RNIN -14%. IEP -12%. ENMD -12%. YOKU -11%. SD -8%. LYG -8%. CWH -6%. RBS -6%. DB -5%. Comment! [On the Move]
Wednesday, January 9, 5:22 PM After-hours top gainers, as of 5:15 p.m.: VOXX +15%. NEWL +9%. SQNM +6%. PSMT +6%. XCO +6%.
After-hours top losers: QUIK -9%. RT -9%. HAFC -7%. NKTR -7%. HALO -7%. 1 Comment [On the Move]
Monday, January 7, 4:03 PM Sequenom (SQNM -2.3%) goes into the close a bit stronger than it started out the day, recovering some of its earlier 6% dip on some upbeat preliminary FY12 guidance posted over the weekend. The company said that it is expecting revenues of $89M, equating to a Y/Y growth rate of 59%, but the results were largely overshadowed by Illumina's (ILMN -7.3%) acquisition of Verinata, whose competing verifi test - which analyzes fetal DNA naturally found in a pregnant women's blood to look for missing or extra copies of chromosomes - carry's less risk than Sequenom’s SEQureDx technology. 2 Comments [Healthcare, Earnings, On the Move]
Monday, January 7, 9:10 AM Premarket gainers: PPHM +27%. CBMX +25%. EPOC +22%. NSM +18%. ES +11%. VVUS +10%. WAC +9%. KERX +6%. SCTY +6%. NCT +6%.
Losers: ILMN -9%. SQNM -6%. 2 Comments [On the Move]

freefdawatchlist
http://bit.ly/W2uOeA Stocks for Nov 12th: $AAPL,$PCP, $MYRX, $FSYS, $SIM, $STSI, $SQNM, $MCP
11/11/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ZetaKap
4 Highly Liquid Small Cap Healthcare Stocks Set For Growth http://bit.ly/QiCgm0 $NAVB $PODD $SGNT $SQNM @ZetaKap
9/4/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

freefdawatchlist
http://stks.co/j9yD Premarket loser: $PWRD, $SCHN, $ERIC, $MNST, $ASML Premarket Gainer: $CYBX, $DEPO, $SQNM, $DRYS
8/28/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

freefdawatchlist
http://bit.ly/RgqUkg After hour gainers $NILE (22%) $OPEN(14%) $MELI(13%) $SKUL(7%) LNKD(7%) SQNM(7%) $UVXY $TVIX $VXX
8/3/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ZetaKap
3 Analyst Endorsed Small Cap Biotech Stocks Slated For Growth http://bit.ly/N684rX $AFFY $IDIX $SQNM @ZetaKap
8/2/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ZetaKap
4 Healthcare Stocks Primed For Growth http://bit.ly/OPKePj $AKRX $AUXL $PODD $SQNM @ZetaKap
7/27/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Marty Chilberg
Interested in chatting about SQNM? check out new group at http://bit.ly/MdFHLL
7/9/12
Reply (1)

• !Report Abuse
View all 1 replies
Gostem: Hello I am an individual investor with a large position in SQNM for a number of years. I would like to join your group. Thank you, Eric
Feb 27, 9:04 PM
• !Report Abuse
Add a reply...

140 characters

freefdawatchlist
http://bit.ly/OwcFWa July 5th After hours gainer $XRTX, $CLDX, $SQNM, $FSC, $VT, $PCXCQ.OB, $DNR, $TC, $ZLCS, $CFBK, $SSH
7/6/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ZetaKap
4 Cash Heavy Small Cap Biotech Stocks Trading Near 52-Week Lows http://bit.ly/MKN7QV $EBS $PACB $SHP $SQNM @ZetaKap
6/14/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

freefdawatchlist
http://bit.ly/L1LWQx After hours big loser TAL, INVN, BODY, ANIK, QLGC, CBOU, PACB, SQNM
5/3/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES

Marty Chilberg
Interested in chatting about SQNM? check out new group at http://bit.ly/MdFHLL
7/9/12
Reply (1)

• !Report Abuse
View all 1 replies
Gostem: Hello I am an individual investor with a large position in SQNM for a number of years. I would like to join your group. Thank you, Eric
Feb 27, 9:04 PM
• !Report Abuse
Add a reply...

140 characters

freefdawatchlist
http://bit.ly/KW1sxj Earnings after hours: $AIG $BEBE, $BODY $CADX $CNQ $CF $DOLE $EXEL $ISTA $MDLZ $KOG $LNKD $SD $SPRD $SQNM $ZAG
5/3/12
Reply (3)

• !Report Abuse
View all 3 replies
cn_habs: NES is up 12% in AH yet missed earnings...
5/3/12
• !Report Abuse
freefdawatchlist: AIG is down 2%, LNKD is up
5/3/12
• !Report Abuse
Add a reply...

140 characters

SQNM Sequenom, Inc.

SQNM

Sequenom, Inc.